Gemini Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
- Paid Up Capital ₹ 2.20 Cr
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.27 Cr
- Revenue Growth -9.43%
- Profit Growth 73.92%
- Ebitda 70.42%
- Net Worth 4.40%
- Total Assets -8.77%
About Gemini Pharmaceuticals
Gemini Pharmaceuticals Limited (GPL) is a Public Limited Indian Non-Government Company incorporated in India on 02 August 2005 and has a history of 19 years and six months. Its registered office is in Muzaffarnagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 2.20 Cr.
The company currently has active open charges totaling ₹5.27 Cr.
Ajay Sharma, Sudhir Kumar, Kuwar Singh, and One other member serve as directors at the Company.
Company Details
-
Location
Muzaffarnagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232UP2005PLC030446
-
Company No.
030446
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
02 Aug 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Gemini Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Sharma
|
Additional Director | 21-Feb-2012 | Current |
|
Sudhir Kumar
|
Director | 01-Oct-2016 | Current |
|
Kuwar Singh
|
Additional Director | 15-Apr-2016 | Current |
|
Ramdev
|
Additional Director | 25-Mar-2023 | Current |
Financial Performance of Gemini Pharmaceuticals.
Gemini Pharmaceuticals Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.43% decrease. The company also saw a substantial improvement in profitability, with a 73.92% increase in profit. The company's net worth moved up by a moderate rise of 4.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gemini Pharmaceuticals?
In 2020, Gemini Pharmaceuticals had a promoter holding of 25.64% and a public holding of 74.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ravi Organics LimitedAjay Sharma, Kuwar Singh and 1 more are mutual person
-
Divera Solutions Limited
Ajay Sharma, Sudhir Kumar and 2 more are mutual person
-
Sunagro Insecticides Private Limited
Kuwar Singh and Ramdev are mutual person
-
Aarla Foods (India) Private Limited
Kuwar Singh is a mutual person
-
Blue Diamond Industries Limited
Kuwar Singh and Ramdev are mutual person
-
Divera Infrastructure And Projects Limited
Kuwar Singh is a mutual person
Charges (Loans)
₹5.27 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 5.27 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2006 | State Bank Of India | ₹5.27 Cr | Open |
How Many Employees Work at Gemini Pharmaceuticals?
Gemini Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gemini Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gemini Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
